What CDC is Doing

AFM Investigation

CDC thoroughly investigates every reported AFM case by looking for possible risk factors and causes, figuring out why some people develop this condition, monitoring AFM activity nationwide, and updating possible treatment options.

AFM Research

CDC’s research focuses on

  • enhancing surveillance for AFM so that all cases are identified and reported to CDC
  • describing clinical characteristics of patients with AFM, including their symptoms, test results, treatments received, and outcomes
  • identifying viral causes of AFM
  • improving strategies for communicating with and educating clinicians

To learn more about participating in AFM Research, visit How to Get Involved in Research.

Supporting Health Departments

CDC provides guidance and tools for health departments for reporting AFM cases. We also support states that want to confirm their own cases by providing standard operating procedures, a medical chart abstraction tool, and training on how to interpret the information.

Educating Clinicians

CDC collaborates with health departments and partners to educate clinicians so they are aware of the symptoms of AFM, how to report suspected cases of AFM, what specimens to collect, and the clinical guidance for patients with AFM. Educational activities and materials include health alerts, job aids, toolkits, webinars, and scientific publications and presentations. Learn more.

Communicating with Parents

CDC collaborates with a group of parents who offer support to children with AFM and their families. Together, we are working to raise awareness about AFM and share information and resources.

Providing Treatment Considerations

CDC and experts in a range of disciplines developed clinical guidance for the acute medical treatment of AFM of patients with AFM. We are continuing to explore and update these as more is discovered about AFM.

The AFM Task Force

The Acute Flaccid Myelitis Task Force is a nationwide group of physicians, scientists, and public health experts from a variety of disciplines and institutions. The Task Force is committed to moving the AFM research agenda forward to better understand the causes of AFM, and review and update clinical guidance on the management of patients with AFM.

Page last reviewed: February 25, 2020